The Claim
In mice with diet-induced obesity, 4 weeks of semaglutide treatment reduces skeletal muscle mass and grip strength to the same extent as calorie restriction matched for energy intake, despite achieving greater overall weight loss and fat loss.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In mice with obesity caused by diet, 4 weeks of semaglutide treatment causes the same loss of muscle mass and strength as a calorie-restricted diet with the same number of calories, even though semaglutide leads to more total weight and fat loss.
See the scientific wording
In mice with diet-induced obesity, 4 weeks of semaglutide treatment reduces skeletal muscle mass and grip strength to the same extent as calorie restriction matched for energy intake, despite achieving greater overall weight loss and fat loss, indicating that muscle loss is not uniquely driven by the drug but by caloric deficit.
When the body gets less energy from food, it breaks down muscle proteins to use as fuel. This happens because specific enzymes tag muscle proteins for destruction, and the muscle stops building new proteins as much. As a result, muscles shrink and get weaker. When food intake returns to normal, the muscle rebuilds itself.
What the research says
1 studyIn obese mice, taking semaglutide and eating fewer calories caused the same amount of muscle weakness and shrinkage, even though the drug made them lose more fat. This suggests it’s the reduced food intake, not the drug itself, that causes muscle loss.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.